European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 276-279, April 2010

How much more effective do depot antipsychotics have to be compared to oral antipsychotics before they are prescribed?

Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München, Germany

Received 2 December 2009; received in revised form 5 January 2010; accepted 11 January 2010. published online 04 February 2010.

Abstract 

Antipsychotic depots are less frequently prescribed than oral compounds. In an experimental study involving N=106 psychiatrists we studied how much more effective with respect to relapse prevention depot antipsychotics have to be compared to oral antipsychotics before they are chosen for prescription.

Most psychiatrists have to judge depot as clearly superior with respect to relapse prevention before they recommend it to patients. If psychiatrists judge depot as unpleasant for the patients and do not see much need for checking their patients' compliance they are less likely to prescribe depot. Other psychiatrist-related factors (e.g. age, gender, and work experience) did not influence attitudes toward depot.

Keywords: Schizophrenia, Antipsychotics, Depot, Effectiveness, Prescription rates

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0924-977X(10)00005-2

doi:10.1016/j.euroneuro.2010.01.001

European Neuropsychopharmacology
Volume 20, Issue 4 , Pages 276-279, April 2010